Evaluation of the Videodrama Therapeutic Device for Children With Autism Spectrum Disorders

NCT ID: NCT06443320

Last Updated: 2025-02-06

Basic Information

• Recruitment Status: RECRUITING
• Clinical Phase: NA
• Total Enrollment: 30 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2023-12-04
• Study Completion Date: 2027-03-04

Brief Summary

Autism spectrum disorder (ASD) is a neurodevelopmental disorder (Valerie, Sperenza, 2009) that begins early in development, characterized by persistent deficits in communication and social interactions across various contexts and restricted, repetitive patterns of behavior, interests, or activities. These symptoms significantly impact social, school/professional functioning, or other important areas and are not better explained by intellectual disability or global developmental delay (American Psychiatric Association, 2013).

Detailed Description

Currently, managing children with ASD emphasizes compensating for communication and social interaction disabilities. Communication tools like PECS or Makaton and social skills groups have shown effectiveness but have limitations, particularly not addressing sensory atypicalities seen in children with ASD. These sensory atypicalities are evident when children watch videos on screens. The idea is to use video to understand the sensory experiences of children with ASD and help them move away from an isolated relationship with screens. New technologies can further isolate children with ASD in their autistic sphere. The hypothesis is that observing these children with screens will provide better understanding of their sensory experiences and improve therapeutic support towards play and interaction with others

Conditions

Autism Spectrum Disorder (ASD)

Study Design

• Allocation Method: NON_RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: SUPPORTIVE_CARE
• Blinding Strategy: NONE

Study Groups

Group of young ASD patients receiving videodrama sessions and interviews

Children participating in videodrama sessions, one per week for 9 sessions.

Group Type: EXPERIMENTAL

patient included in experimental groupe will view the video excerpt, a playtime, a drawing activities

Intervention Type: OTHER

Patients included in the videodrama arm will participate in a total of 18 videodrama sessions, with one session per week. Each session will include a patient welcome period, the viewing of a video excerpt (in slow motion or not), a playtime, a drawing period, and a group closing session. For the play and drawing activities, the same materials will be provided in each department and for each group, including small figurines, animals, shapes (such as cubes, triangles, circles), small plush toys, markers, colored pencils, and A4 white sheets of paper.

Cohort of ASD patients not receiving videodrama but receiving care in participating units

Patients included in the cohort will be managed as part of their routine care

Group Type: NO_INTERVENTION

No interventions assigned to this group

Interventions

patient included in experimental groupe will view the video excerpt, a playtime, a drawing activities

Patients included in the videodrama arm will participate in a total of 18 videodrama sessions, with one session per week. Each session will include a patient welcome period, the viewing of a video excerpt (in slow motion or not), a playtime, a drawing period, and a group closing session. For the play and drawing activities, the same materials will be provided in each department and for each group, including small figurines, animals, shapes (such as cubes, triangles, circles), small plush toys, markers, colored pencils, and A4 white sheets of paper.

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• Children aged 3 to 15 years.
• Clinically confirmed ASD by a psychiatrist.
• Parental or legal guardian consent for participation.
• Child showing a strong interest in screens and/or video content.
• Ability to tolerate the presence of other children.
• Minimum of 18 video drama sessions.
• Not having benefited from disease care in the past.
• Affiliation to a social security system

Exclusion Criteria

• No ASD diagnosis.
• Younger than 3 or older than 15 at the study start.
• No interest in screens or video content.
• Parental or legal guardian refusal for participation.
• Dropping out before completing 18 sessions.
• Patient having benefited a disease care in the past

• Minimum Eligible Age: 3 Years
• Maximum Eligible Age: 15 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Centre Hospitalier Intercommunal Robert Ballanger

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Locations

CHI Robert Ballanger

Aulnay-sous-Bois, , France

Site Status: RECRUITING

Countries

France

Central Contacts

Constance LEMARCHAND

Role: CONTACT

constance.lemarchand@ght-gpne.fr

0182372332

Facility Contacts

Mathilde ZERR

Role: primary

mathilde.zerr@ght-gpne.fr

0182372332

Constance LEMARCHAND

Role: backup

constance.lemarchand@ght-gpne.fr

01 49 36 72 50

Other Identifiers

GHT_CHIRB 20220420

Identifier Type: -

Identifier Source: org_study_id